# Primer Capital

Primer Capital is a Private Equity based in Moscow, Russia.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Moscow, Russia
- **Region:** Europe
- **Address:** Moscow, Russia
- **Founded:** 2023
- **Assets under management:** Undisclosed
- **LinkedIn:** https://www.linkedin.com/company/primercapital

## Regulatory record

- **Reports private funds:** No

## About

Primer Capital is a venture capital fund investing in biotech and medical product development companies. The firm has made 17 investments, including a Seed VC investment in Qymune on February 25, 2026. Primer Capital has a single portfolio exit, Acticor Biotech, which exited on November 02, 2021.

## Questions

### What sectors does Primer Capital specifically target?

Primer Capital concentrates on healthcare and life sciences, including pharmaceutical development, medical devices, and healthcare service platforms. This focused mandate distinguishes it from generalist private equity firms operating in Russia, the majority of which allocate primarily to natural resources, real estate, or consumer sectors.

### What stage of companies does Primer Capital typically back?

The firm invests from early-stage venture through growth equity, often entering at points where portfolio companies require scientific diligence alongside capital. Primer Capital participates as both lead investor and syndicate partner, and its holding periods appear aligned with the long development timelines characteristic of therapeutic and medical-device businesses.

## Related profiles

- [Prime Value Capital](https://altss.com/profile/prime-value-capital)
- [Primer Holdings](https://altss.com/profile/primer-holdings)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/primer-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology